ARTICLE | Finance
Panoramic view
VCs flock to Natera's next-generation prenatal test
May 6, 2013 7:00 AM UTC
Natera Inc. raised the fifth biggest venture round for a diagnostic company since the start of 2010, as investors are betting the company's Panorama Prenatal Aneuploidy Test will beat out the competition based on broader coverage and better accuracy.
Last week, Natera raised $54.6 million in a series E round led by new investors OrbiMed Advisors and Harmony Partners. Additional undisclosed new investors participated, along with all the existing investors - Claremont Creek Ventures; Lightspeed Venture Partners; Founders Fund; and Sequoia Capital...